Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Nolvadex Pediatric Exclusivity Extension Would Block Generics Until 2003

Related Content

AstraZeneca Nolvadex Patent Valid Until 2002, Firm Says After Court Ruling

Sep 25 2000

Femara First-Line Breast Cancer Label Includes Tamoxifen Superiority Claim

Jan 15 2001

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window